Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience
CONCLUSIONS: CMV disease leads to significantly inferior survival after an allogeneic hematopoietic cell transplantation. Recipient CMV seropositive status was associated with the risk of CMV viremia and CMV disease, and this was not abrogated with the use of Letermovir prophylaxis.PMID:38513813 | DOI:10.1016/j.trim.2024.102039
Source: Transplant Immunology - Category: Transplant Surgery Authors: Matthew McGuirk Moazzam Shahzad Muhammad Kashif Amin Muhammad Atif Khan Polina Bellman Dinesh Pal Mudaranthakam Shaun DeJarnette Forat Lutfi Nausheen Ahmed Rajat Bansal Haitham Abdelhakim Chelsea Gorsline Dennis Matthew Shoemaker Al-Ola Abdallah Leyla Shu Source Type: research
More News: Allergy & Immunology | Cytomegalovirus | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants